For: | Kilic L, Ordu C, Yildiz I, Sen F, Keskin S, Ciftci R, Pilanci KN. Current adjuvant treatment modalities for gastric cancer: From history to the future. World J Gastrointest Oncol 2016; 8(5): 439-449 [PMID: 27190583 DOI: 10.4251/wjgo.v8.i5.439] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i5/439.htm |
Number | Citing Articles |
1 |
Juan S. Azagra, Aingeru Sarriugarte, Francisco Javier Ibañez. Estado actual de la gastrectomía por cáncer. «Less is often more». Cirugía Española 2018; 96(10): 603 doi: 10.1016/j.ciresp.2018.04.005
|
2 |
Nayla Mouawad, Maguie El Boustani, Vincenzo Canzonieri, Isabella Caligiuri, Flavio Rizzolio. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 213 doi: 10.1007/978-3-030-04861-7_13
|
3 |
Araz Kouyoumdjian, Maude Trepanier, Ruqaiya Al Shehhi, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Lawrence Lee, Carmen L. Mueller. The Effect of Preoperative Anemia and Perioperative Transfusion on Surgical Outcomes After Gastrectomy for Gastric Cancer. Journal of Surgical Research 2021; 259: 523 doi: 10.1016/j.jss.2020.10.003
|
4 |
Joshua P. Kronenfeld, Amber L. Collier, Michael K. Turgeon, Michelle Ju, Rodrigo Alterio, Annie Wang, Manuel Fernandez, Matthew R. Porembka, Harry Richter, Ann Y. Lee, Maria C. Russell, Nipun B. Merchant, Ajay V. Maker, Jashodeep Datta. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety‐Net Collaborative analysis. Journal of Surgical Oncology 2021; 124(8): 1317 doi: 10.1002/jso.26638
|
5 |
Juan S. Azagra, Aingeru Sarriugarte, Francisco Javier Ibañez. Current Status of Gastrectomy for Cancer: “Less Is Often More”. Cirugía Española (English Edition) 2018; 96(10): 603 doi: 10.1016/j.cireng.2018.04.002
|
6 |
Junjie Zhao, Xuhong Fu, Hao Chen, Lingqiang Min, Jie Sun, Jingyi Yin, Jianping Guo, Haojie Li, Zhaoqing Tang, Yuanyuan Ruan, Xuefei Wang, Yihong Sun, Liyu Huang. G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer. British Journal of Cancer 2021; 124(2): 425 doi: 10.1038/s41416-020-01067-1
|
7 |
He-Li Liu, Huan Peng, Chang-Hao Huang, Hai-Yan Zhou, Jie Ge. Mutational separation and clinical outcomes of <i>TP53</i> and <i>CDH1</i> in gastric cancer. World Journal of Gastrointestinal Surgery 2023; 15(12): 2855-2865 doi: 10.4240/wjgs.v15.i12.2855
Abstract(277) |
Core Tip(228) |
Full Article(HTML)(942)
|
Full Article with Cover (PDF)-2298K(84)
|
Full Article (Word)-996K(14)
|
Audio-145K(4)
|
Peer-Review Report-223K(31)
|
Answering Reviewers-292K(26)
|
Full Article (PDF)-2003K(54)
|
Full Article (XML)-129K(29)
|
Times Cited (1)
|
Total Visits (2993)
|
Open
|
8 |
Hemant Kumar Singh, Vikram Chaudhari, Swati Batra, Vikas Ostwal, Anant Ramaswamy, Smruti Mokal, Shailesh V. Shrikhande, Manish S. Bhandare. Radical D2 gastrectomy with adjuvant chemotherapy for stage IB/II/III distal gastric cancers in the era of perioperative chemotherapy: A propensity matched comparison. The American Journal of Surgery 2022; 223(6): 1055 doi: 10.1016/j.amjsurg.2021.10.036
|
9 |
Roberto Camacho Barranco, Raimundo F. Dos Santos, M. Shahriar Hossain, Monika Akbar. Tracking the Evolution of Words with Time-reflective Text Representations. 2018 IEEE International Conference on Big Data (Big Data) 2018; : 2088 doi: 10.1109/BigData.2018.8621902
|
10 |
Zining Liu, Yinkui Wang, Fei Shan, Xiangji Ying, Yan Zhang, Shuangxi Li, Yongning Jia, Ziyu Li, Jiafu Ji. 5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?. Cancer Management and Research 2021; : 147 doi: 10.2147/CMAR.S285361
|
11 |
Cheng Chen, Cheng Wu Tang, San Xiong Huang, Chun Lei Shen. Efficacy and Safety of Additional S-1 Chemotherapy to S-1 Plus Oxaliplatin Regimen Chemotherapy for Stage III Gastric Carcinoma after Radical Resection. Cancer Investigation 2022; 40(1): 73 doi: 10.1080/07357907.2021.1988961
|
12 |
Eiji Hishinuma, Evelyn Gutiérrez Rico, Masahiro Hiratsuka. In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase. Journal of Clinical Medicine 2020; 9(8): 2342 doi: 10.3390/jcm9082342
|
13 |
Melina Arnold, Eileen Morgan, Aude Bardot, Mark J Rutherford, Jacques Ferlay, Alana Little, Bjorn Møller, Oliver Bucher, Prithwish De, Ryan R Woods, Nathalie Saint-Jacques, Anna T Gavin, Gerda Engholm, Michael P Achiam, Geoff Porter, Paul M Walsh, Sally Vernon, Serena Kozie, Agnihotram V Ramanakumar, Charlotte Lynch, Samantha Harrison, Neil Merrett, Dianne L O’Connell, Tom Mala, Mark Elwood, John Zalcberg, Dyfed W Huws, David Ransom, Freddie Bray, Isabelle Soerjomataram. International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut 2021; : gutjnl-2021-325266 doi: 10.1136/gutjnl-2021-325266
|
14 |
Sung Ho Jang, Young Jae Jung, Min Gyu Kim, Sung Joon Kwon. The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study. Journal of Gastric Cancer 2018; 18(1): 48 doi: 10.5230/jgc.2018.18.e4
|
15 |
Kyoung Jin Lee, Seol Hwa Shin, Jae Hee Lee, Eun Jin Ju, Yun-Yong Park, Jung Jin Hwang, Young-Ah Suh, Seung-Mo Hong, Se Jin Jang, Jung Shin Lee, Si Yeol Song, Seong-Yun Jeong, Eun Kyung Choi. A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials 2017; 141: 136 doi: 10.1016/j.biomaterials.2017.06.037
|
16 |
Melissa A. Jim, Paulo S. Pinheiro, Helena Carreira, David K. Espey, Charles L. Wiggins, Hannah K. Weir. Stomach cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study. Cancer 2017; 123(S24): 4994 doi: 10.1002/cncr.30881
|